We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock

Delisted

CDMO was delisted on the 4th of February, 2025.

174 hedge funds and large institutions have $381M invested in Avid Bioservices, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 58 increasing their positions, 50 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more call options, than puts

Call options by funds: $218K | Put options by funds: $82K

16% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 50

13% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 39

2% more funds holding

Funds holding: 170174 (+4)

36% less capital invested

Capital invested by funds: $591M → $381M (-$210M)

Holders
174
Holders Change
+4
Holders Change %
+2.35%
% of All Funds
2.54%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
44
Increased
58
Reduced
50
Closed
39
Calls
$218K
Puts
$82K
Net Calls
+$136K
Net Calls Change
+$127K

CDMO Hedge Fund Activity: Q4 2023 in Review

174 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q4 2023, worth a combined $381M — down 36% from $591M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new CDMO positions and 39 closed out — a net gain of 5 holders — while 58 added to existing stakes and 50 trimmed.

The largest buyer was Millennium Management, adding an estimated $26.9M. The largest seller was BlackRock, cutting an estimated $28.3M.

  • 174 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q4 2023, up from 170 in Q3 2023.
  • Funds reported $381M of Avid Bioservices, Inc. Common Stock stock for Q4 2023, down 36% quarter-over-quarter.
  • 44 funds opened new Avid Bioservices, Inc. Common Stock positions in Q4 2023 and 39 closed out, a net change of +5 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q4 2023 was Millennium Management, an estimated $26.9M added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q4 2023 was BlackRock, an estimated $28.3M sold.

Based on aggregated 13F filings for Q4 2023.